Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Jarosawiecka AK, Piotrowska-Seget Z
Monitor Regulatory Developments: The GLP-1 space is evolving rapidly, and FDA may issue further clarifications or enforcement actions impacting both 503Bs and 503As
doi: 10.3389/fendo.2025.1683419 Received 12 August 2025 Revised 04 December 2025 Accepted 30 December 2025 Published 23 January 2026 Volume 16 - 2025 Edited by Claudia Lagranha, Federal University of Pernambuco, Brazil Reviewed by Lei Zhao, China Medical University, China Michihiro Takahashi, Takahashi Psychiatric Clinic, Japan Sundararajan Mahalingam, University of Nebraska Omaha, United States Rodolfo Nunes, Federal University of Ceara, Brazil Updates Copyright 2026 Doval-Caballero, Ferreira-Hermosillo, Eugenio-Ponce, Garca-Senz, Ibarra-Salce, Tenorio-Rojo, Luna-Avila, Gete-Palacios, Prez-Hernndez, Rojas-Miln, Lpez-Cruz and Mndez-Hernndez
Handling is restricted to trained and properly licensed professionals
Our findings challenge the view that filamentation is essential for C
,aspect=ignore)
US$ 27.23
US$ 28.87
US$ 25.52
